Appointment of liquidators (MVL)
Amryt Pharma (UK) Limited enters members' voluntary liquidation
In short: Amryt Pharma (UK) Limited (company no. 10463152) entered members' voluntary liquidation, a solvent and planned closure, according to a Appointment of liquidators (MVL) notice published in The London Gazette on 20 July 2026. The office holders are James Hawksworth of RSM UK Restructuring Advisory LLP, 25 Farringdon Street, London, EC4A 4AB; Terence Guy Jackson of RSM UK Restructuring Advisory LLP, Third F, appointed 9 July 2026. The company's business: wholesale of pharmaceutical goods.
The members of AMRYT PHARMA (UK) LIMITED have appointed James Hawksworth and Terence Guy Jackson as liquidators on 9 July 2026.
Notice details
- Company
- AMRYT PHARMA (UK) LIMITED
- Company number
- 10463152
- Nature of business
- Wholesale of pharmaceutical goods
- Registered office
- C/O Corporation Service Company (UK) Limited, 5 Churchill Place, 10th Floor, London E14 5HU
- Type of liquidation
- Members
- Date of appointment
- 9 July 2026
- Office holder(s)/Liquidator(s)
- James Hawksworth of RSM UK Restructuring Advisory LLP, 25 Farringdon Street, London, EC4A 4AB; Terence Guy Jackson of RSM UK Restructuring Advisory LLP, Third Floor, One London Square, Cross Lanes, Guildford, GU1 1UN
- Office holder number(s)
- 22450; 16450
- Appointed by
- Members
What this notice means
A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Read more: What is Liquidation?.
All notices for Amryt Pharma (UK) Limited
3 Gazette notices on record for company no. 10463152, newest first. The full history, with last filed accounts, is on the Amryt Pharma (UK) Limited company record.
- Notices to creditors (MVL) 20 Jul 2026
- Resolution for winding up (MVL) 20 Jul 2026
How does this notice affect you?
Choose what applies and we'll point you at the right next step.
A written-off invoice rarely stops at the company that failed. The supplier left short is often the next business in difficulty — and the earlier that's dealt with, the more options stay open. If AMRYT PHARMA (UK) LIMITED owed you money, it's worth checking where that leaves you.
Unpaid wages, holiday pay and statutory redundancy are claimed from the government's Redundancy Payments Service, not from K2. The insolvency practitioner named in this notice should send you a case reference — you'll need it to claim.
K2's founder has turned around UK businesses since 1990, and K2 has backed and restructured them since 2001, including buying trade and assets out of distress. These situations move in days rather than months, so if you're looking at AMRYT PHARMA (UK) LIMITED or something similar, start the conversation early.
A members' voluntary liquidation is a solvent, orderly closure — often part of retirement, a group restructure, or moving on to the next venture. K2's founder has advised UK company directors since 1990 on restructuring and what comes next. If that's on your horizon, talk to us.
Related guidance
Free, practical guides from K2 on what this kind of notice means for directors.
More liquidation notices
Frequently asked questions
Is Amryt Pharma (UK) Limited in financial difficulty?
No — this is a solvent process. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The London Gazette published a Appointment of liquidators (MVL) for Amryt Pharma (UK) Limited (company no. 10463152) on 20 July 2026.
What does a Appointment of liquidators (MVL) mean?
A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Who is dealing with the liquidation?
The office holders named in the notice: James Hawksworth of RSM UK Restructuring Advisory LLP, 25 Farringdon Street, London, EC4A 4AB; Terence Guy Jackson of RSM UK Restructuring Advisory LLP, Third F, appointed 9 July 2026. Creditors, employees and anyone holding goods or money belonging to the company should contact them directly, quoting the company number.
Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.